BridgeMD
New treatment option for Lung Carcinoma
Official title PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
ClinicalTrials.gov ID: NCT05775939
What this study is testing
- What it's testing
- This clinical trial examines positron emission tomography (PET)/computed tomography (CT) in evaluating cardiac radiation damage in patients with lung or esophageal cancer. As part of the treatment for lung or esophageal cancer, patients will undergo radiation therapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, aged \>= 18
- Life expectancy \>= 3 months as assessed by Radiation Oncologist
- Mean heart dose estimated by Radiation Oncologist to be \>= 5 Gy (physics dose or biologically equivalent dose)
You likely can't join if
- Contraindication for FDG PET-CT scans as assessed by the radiation oncologist or nuclear medicine radiologist
- Palliative radiation doses defined as 20 Gy in 5 fractions
See the full eligibility criteria
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, aged \>= 18
- Life expectancy \>= 3 months as assessed by Radiation Oncologist
- Mean heart dose estimated by Radiation Oncologist to be \>= 5 Gy (physics dose or biologically equivalent dose)
- Pathologically proven (either histologic or cytologic) proven lung cancer or esophageal cancer
- Planned radiation treatment course for management of lung or esophageal cancer \ Both standard and hypofractionation schedules are permitted
- Contraindication for FDG PET-CT scans as assessed by the radiation oncologist or nuclear medicine radiologist
- Palliative radiation doses defined as 20 Gy in 5 fractions
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.